News | December 08, 2008

Slower Heart Rate May Translate into Longer Life

December 9, 2008 - Slowing heart rate with exercise and stress reduction may help extend life, reports the December 2008 issue of the Harvard Heart Letter.

Sixty years ago, researchers showed that men with fast resting heart rates were more likely to develop high blood pressure than those with slower rates. Since then, a high resting heart rate has been linked to atherosclerosis, sudden death, and an increased risk of dying from cardiovascular disease. The article states each pulse of blood puts a mild stress on artery walls. More beats per minute means more stress. A faster heartbeat also gives the coronary arteries less time to fill with blood. This can lead to an imbalance between heart cells’ demand for oxygen and the heart’s ability to provide it.

Resting heart rate seems to be a common denominator for various types of heart disease. A tantalizing possibility is that lowering your heart rate could help protect you from heart disease and may even let your heart beat for longer.

The Harvard Heart Letter notes that if a resting heart rate is high, patients can do something about it by exercising more and reducing stress. Exercising every day gradually slows the resting rate. The relaxation response, meditation, and other stress-busting techniques also lower heart rate over time.

For more information: www.health.harvard.edu/heart


Related Content

News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

Home April 08, 2024
Home
Subscribe Now